Johanna A Kremer Hovinga (Johanna Anna Kremer Hovinga, J A Kremer Hovinga)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Topics

Venous Thromboembolism

Helicobacter Pylori

Chronic Lymphocytic Leukemia

Top Venues

Journal of thrombosis and haemostasis : JTH

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Roman R Schimmer, Tabea Sutter, Adrian Bachofner, Elisabetta Ranieri, Ann-Kathrin Rodewald, Johanna A Kremer Hovinga, Nina Kimmich, Alice Trinchero, Jan-Dirk Studt
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab. British journal of haematology 204 (5) (2024)
Roman R Schimmer, Tabea Sutter, Adrian Bachofner, Elisabetta Ranieri, Ann-Kathrin Rodewald, Johanna A Kremer Hovinga, Nina Kimmich, Alice Trinchero, Jan-Dirk Studt
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab. British journal of haematology 204 (5) (2024)
Roman R Schimmer, Tabea Sutter, Adrian Bachofner, Elisabetta Ranieri, Ann-Kathrin Rodewald, Johanna A Kremer Hovinga, Nina Kimmich, Alice Trinchero, Jan-Dirk Studt
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab. British journal of haematology (2024)
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Emanuel Schmidt, Walter A Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A Kremer Hovinga, Tamam Bakchoul, Fabrice Cognasse, Michael Nagler
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood advances (2024)
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Emanuel Schmidt, Walter A Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A Kremer Hovinga, Tamam Bakchoul, Fabrice Cognasse, Michael Nagler
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood advances 8 (11) (2024)
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Emanuel Schmidt, Walter A Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A Kremer Hovinga, Tamam Bakchoul, Fabrice Cognasse, Michael Nagler
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood advances 8 (11) (2024)
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Emanuel Schmidt, Walter A Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A Kremer Hovinga, Tamam Bakchoul, Fabrice Cognasse, Michael Nagler
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood advances 8 (11) (2024)
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Emanuel Schmidt, Walter A Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A Kremer Hovinga, Tamam Bakchoul, Fabrice Cognasse, Michael Nagler
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood advances 8 (11) (2024)
Anita A G A van de Munckhof, Erik Lindgren, Timothy John Kleinig, Thalia S Field, Charlotte Cordonnier, Katarzyna Krzywicka, Sven Poli, Mayte Sánchez van Kammen, Afshin Borhani-Haghighi, Robin Lemmens, Adrian Scutelnic, Alfonso Ciccone, Thomas Gattringer, Matthias Wittstock, Vanessa Dizonno, Annemie Devroye, Ahmed Elkady, Albrecht Günther, Alvaro Cervera, Annerose Mengel, Beng Lim Alvin Chew, Brian H Buck, Carla Zanferrari, Carlos Garcia-Esperon, Christian Jacobi, Cristina Soriano, Dominik Michalski, Zohreh Zamani, Dylan Blacquiere, Elias Johansson, Elisa Cuadrado Godia, Fabrice Vuillier, Felix J Bode, Francois Caparros, Frank Maier, Georgios K Tsivgoulis, Hans D Katzberg, Jiangang Duan, Jim Burrow, Johann Pelz, Joshua Mbroh, Joyce Oen, Judith Schouten, Julian Zimmermann, Karl Ng, Katia Garambois, Marco Petruzzellis, Mariana Carvalho Dias, Masoud Ghiasian, Michele Romoli, Miguel A Miranda, Miriam Wronski, Mona Skjelland, Mostafa Almasi-Dooghaee, Pauline Cuisenier, Seán Murphy, Serge Timsit, Shelagh B Coutts, Silvia Schönenberger, Simon Nagel, Sini Hiltunen, Sophie Chatterton, Thomas Cox, Thorsten Bartsch, Vahid Shaygannejad, Zahra Mirzaasgari, Saskia Middeldorp, Marcel M Levi, Johanna A Kremer Hovinga, Katarina Jood, Turgut Tatlisumak, Jukka Putaala, Mirjam Rachel Heldner, Marcel Arnold, Diana Aguiar de Sousa, Jose M Ferro, Jonathan M Coutinho, null null
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke 53 (10) (2022)
Erika Tarasco, Anne Sophie von Krogh, Radomira Hrdlickova, Thomas R Braschler, Teresa Iwaniec, Paul N Knöbl, Eriko Nakamura, Oleg Pikovsky, Stefan Farese, Odit Gutwein, Petr Kessler, Nina H Schultz, Charis von Auer, Jerzy Windyga, Kenneth Friedman, Ingrid Hrachovinova, James N George, Masanori Matsumoto, Reinhard Schneppenheim, Bernhard Lämmle, Johanna A Kremer Hovinga
Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease. Research and practice in thrombosis and haemostasis 6 (7) (2022)
Azra Borogovac, Erika Tarasco, Johanna A Kremer Hovinga, Kenneth D Friedman, Adam S Asch, Sara K Vesely, Calin I Prodan, Deirdra R Terrell, James N George
Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura. Blood 140 (7) (2022)
Katarzyna Krzywicka, Anita A G A van de Munckhof, Julian Zimmermann, Felix J Bode, Giovanni Frisullo, Theodoros Karapanayiotides, Bernd Pötzsch, Mayte Sánchez van Kammen, Mirjam Rachel Heldner, Marcel Arnold, Johanna A Kremer Hovinga, Jose M Ferro, Diana Aguiar de Sousa, Jonathan M Coutinho
Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose. Blood 139 (17) (2022)
Kristina Vrotniakaite-Bajerciene, Tobias Tritschler, Katarzyna Aleksandra Jalowiec, Helen Broughton, Justine Brodard, Naomi Azur Porret, Alan G Haynes, Alicia Rovo, Johanna A Kremer Hovinga, Drahomir Aujesky, Anne Angelillo-Scherrer
Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study. Journal of clinical medicine 11 (14) (2022)
Silvan R Heeb, Monica Schaller, Johanna A Kremer Hovinga
Naturally Occurring Anti-Idiotypic Antibodies Portray a Largely Private Repertoire in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Journal of immunology (Baltimore, Md. : 1950) 208 (11) (2022)
Marie Anne Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul N Knöbl, Flora Peyvandi, Spero R Cataland, Paul Coppo, Johanna A Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Filip Callewaert, Sriya Gunawardena, Julie Lin
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Jana Van den Berg, Johanna A Kremer Hovinga, Claudia Pfleger, Inga Hegemann, Gregor Thomas Stehle, Andreas Holbro, Jan-Dirk Studt
Daratumumab for immune thrombotic thrombocytopenic purpura. Blood advances (2021)
Justine Brodard, Johanna A Kremer Hovinga, Pierre Fontana, Jan-Dirk Studt, Andreas Greinacher, Andreas Greinacher
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies. Journal of thrombosis and haemostasis : JTH 19 (5) (2021)
Erika Tarasco, Lukas Bütikofer, Kenneth D Friedman, James N George, Ingrid Hrachovinova, Paul N Knöbl, Masanori Matsumoto, Anne Sophie von Krogh, Isabella Aebi-Huber, Zuzana Cermakova, Magdalena Górska-Kosicka, Katarzyna Aleksandra Jalowiec, Carlo R Largiadèr, Zoltán Proházka, György Sinkovits, Jerzy Windyga, Bernhard Lämmle, Johanna A Kremer Hovinga
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood 137 (25) (2021)
Alexandru Grigorean, Stefanie Sollfrank, Alice Trinchero, Anke Adenaeuer, Hassan Abolghasemi, Laura Conti, Friederike Häuser, Johanna A Kremer Hovinga, Karl J Lackner, Felicia Loewecke, Erwin Miloni, Nader Vazifeh Shiran, Luigi Tomao, Walter A Wuillemin, Barbara Zieger, Bernhard Lämmle, Heidi Rossmann
Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence. Journal of thrombosis and haemostasis : JTH 18 (7) (2020)
Azra Borogovac, Erika Tarasco, Johanna A Kremer Hovinga, James N George
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura. EJHaem 1 (1) (2020)
Anne Angelillo-Scherrer, Behrouz Mansouri Taleghani, Frauke Förger, Gabriela M Baerlocher, Thomas Pabst, Alexander Pöllinger, Yara Banz, Thomas Geiser, Johanna A Kremer Hovinga, Alicia Rovó
Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome. Blood advances 3 (17) (2020)
Zsuzsanna Z Orosz, Helga Bárdos, Amir H Shemirani, Ildikó Beke Debreceni, Riitta Lassila, Antti S Riikonen, Johanna A Kremer Hovinga, Theo G Seiler, Hendrika A van Dorland, Verena Schroeder, Zoltán Boda, László Nemes, Beatrice Früh Eppstein, Bence Nagy, Andrea Facskó, János Kappelmayer, László Muszbek
Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes. International journal of molecular sciences 20 (23) (2019)
Judith Robertz, Martin Andres, Behrouz Mansouri Taleghani, Irene Koneth, Isabelle Binet, Johanna A Kremer Hovinga
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. American journal of hematology 94 (10) (2019)
Paul Knoebl, Spero R Cataland, Flora Peyvandi, Paul Coppo, Marie Scully, Johanna A Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Hilde De Winter, Filip Callewaert
Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Journal of thrombosis and haemostasis : JTH 18 (2) (2019)
Raja Prince, Luca Bologna, Mirko Manetti, Daniela Melchiorre, Irene Rosa, Natacha Dewarrat, Silvia Suardi, Poorya Amini, José A Fernández, Laurent Burnier, Claudia Quarroz, Maria Desiré Reina Caro, Yasuhiro Matsumura, Johanna A Kremer Hovinga, John H Griffin, Hans-Uwe Simon, Lidia Ibba-Manneschi, François Saller, Sara Calzavarini, Anne Angelillo-Scherrer
Targeting anticoagulant protein S to improve hemostasis in hemophilia. Blood 131 (12) (2018)
Johanna A Kremer Hovinga, S R Heeb, M Skowronska, M Schaller
Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Journal of thrombosis and haemostasis : JTH 16 (4) (2018)
Evaren E Page, Johanna A Kremer Hovinga, Deirdra R Terrell, Sara K Vesely, James N George
Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood 128 (17) (2016)
Robert Kölm, Monica Schaller, Lubka T Roumenina, Iga Niemiec, Johanna A Kremer Hovinga, Elham Khanicheh, Beat A Kaufmann, Helmut Hopfer, Marten Trendelenburg
Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling. Journal of immunology (Baltimore, Md. : 1950) 197 (9) (2016)